Takeda Pharmaceutical Co Adr (TAK)

Jan 17, 2025

Global Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica - GlobeNewswire Inc.

Jan 17, 2025

Jan 14, 2025

Weekly Upgrades and Downgrades - InvestorPlace

Jan 14, 2025

Nov 30, 2024

Saudi Arabia Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Nov 30, 2024

Nov 28, 2024

Dr. Kevan Jacobson and Dr. Genelle Lunken Awarded $1M Pioneer Grant for Transformative Pediatric Research in Inflammatory Bowel Disease - Quantisnow

Nov 28, 2024

Nov 22, 2024

Things To Consider Before You Buy Takeda Pharmaceutical Co ADR (NYSE: TAK) - Stocks Register

Nov 22, 2024

Nov 22, 2024

Capital One Financial Corp (NYSE: COF): Overvalued In Comparison To Others? - Stocks Register

Nov 22, 2024

Nov 21, 2024

Takeda and Alloy Therapeutics partner to make off-the-shelf CAR-T therapies - MSN

Nov 21, 2024

Nov 20, 2024

Alloy Therapeutics Signs Collaboration and License Agreement with Takeda to Develop Cell Therapy Platform - Quantisnow

Nov 20, 2024

Nov 20, 2024

Australia Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Nov 20, 2024

Nov 20, 2024

Denmark Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Nov 20, 2024

Nov 18, 2024

Italy Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Nov 18, 2024

Nov 18, 2024

UK Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Nov 18, 2024

Nov 18, 2024

South Africa Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Nov 18, 2024

Nov 06, 2024

T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - GlobeNewswire Inc.

Nov 06, 2024

Nov 05, 2024

Asian Equities Traded in the US as American Depositary Receipts Tumble in Wednesday Trading - MSN

Nov 05, 2024

Nov 03, 2024

Earnings call: Takeda reports robust H1 growth, revises full-year guidance - Investing.com Australia

Nov 03, 2024

Nov 03, 2024

Earnings call: Takeda reports robust H1 growth, revises full-year guidance By Investing.com - Investing.com South Africa

Nov 03, 2024

Nov 02, 2024

Torm Plc (NASDAQ: TRMD): Getting A Free Pass? - Stocks Register

Nov 02, 2024

Nov 02, 2024

What Analysts Were Expecting After Checkpoint Therapeutics Inc (NASDAQ: CKPT) rose 2.03% - Stocks Register

Nov 02, 2024

Oct 21, 2024

Spain Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Oct 21, 2024

Oct 21, 2024

Thailand Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Oct 21, 2024

Oct 16, 2024

Dyne Therapeutics Inc (DYN) gets rating Reiterated from Chardan Capital Markets - Knox Daily

Oct 16, 2024

Oct 16, 2024

W & T Offshore Inc (WTI) receives a Buy rating from Stifel - Knox Daily

Oct 16, 2024

Oct 16, 2024

JP Morgan Upgrades Mister Car Wash Inc (MCW) to an Overweight from a Neutral - Knox Daily

Oct 16, 2024

Oct 16, 2024

BofA Securities upgrades Takeda Pharmaceutical Co ADR (TAK) rating to a Buy - Knox Daily

Oct 16, 2024

Oct 16, 2024

What Did We Find About Insider Trading At Ovintiv Inc (NYSE: OVV)? - Stocks Register

Oct 16, 2024

Oct 15, 2024

Mizuho analysts downgrades a Neutral rating for Squarespace Inc (SQSP) - Knox Daily

Oct 15, 2024